House adopts conference report for HB 75 on medical cannabis administration

The Virginia House of Delegates adopted a conference report for House Bill 75 on medical cannabis administration during its March 11 session after a roll-call vote recorded as 95–1.

The lead conferee, identified in the transcript as Delegate Keys Gamar, told the chamber the conference report conforms HB 75 to the enrolled version of SB 332 and moved adoption, saying the terms of the enactment clause are now consistent. "I move the House adopt the conference report," the delegate said as recorded in the transcript.

The clerk closed the roll and reported the tally as "Ayes 95, Nays 1," and the Speaker announced the conference report was agreed to. The clerk told members the conference report is available on the legislative information system.

According to the transcript, HB 75 relates to the administration of medical cannabis to patients and in health facilities; the transcript phrasing on the affected patient group was unclear and described the bill as addressing "terminally ill" patients. The motion was presented as a conformity action—bringing the House wording into alignment with the enrolled Senate measure SB 332—rather than introducing new substantive language on the floor at that moment.

The House took no further floor debate on the measure before adopting the report. The House did not record individual names on the 95–1 roll call in the excerpted transcript beyond the overall tally. The action was announced as final for the House; no implementation timetable or effective date for the bill was discussed in the recorded segment.

The House then moved on to subsequent agenda business and scheduling matters.